U of T and SickKids researchers demonstrate drug stimulation of neural stem cell repair leads to promising impact on treatment of childhood brain injury in survivors of brain cancer

Cross-species study shows that Type 2 diabetes drug metformin could change the way childhood brain injury is treated

Medicine by Design and OIRM invest $1.2 million in technologies and research to advance innovation in regenerative medicine

Twelve targeted projects and two post-doctoral fellowships that are expanding the frontiers of stem cell research will share $1.2 million in funding thanks to programs supported jointly by the University of Toronto’s Medicine by Design initiative and the Ontario Institute for Regenerative Medicine.

Go to Top